GE HealthCare Becomes Standalone Firm After Conglomerate Breakup

GE HealthCare is now a standalone public company after the 2021–2024 breakup of the 130-year-old conglomerate into three firms. The medical imaging division, along with GE Aerospace and GE Vernova, together are worth several times GE's pre-split valuation.

• The separation was led by CEO Larry Culp and completed in 2024, creating a healthcare-focused entity from decades of acquisitions including Amersham ($9.5B, 2004) and Instrumentarium ($2.4B, 2003).
• GE HealthCare's bioprocessing business, originally built from Amersham, was sold to Danaher for $21.4B in 2020, leaving the company concentrated on diagnostic imaging and monitoring.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.